Trial intelligence / Profile preview

Pharmacokinetics of intravenous lidocaine in obese vs non-obese patients undergoing laparoscopic sleeve gastrectomy

ChiCTR2200064980Phase 4Not yet recruiting

Sponsor
Affiliated Hospital of North Sichuan Medical College
Start
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of lidocaine in obesity (2 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoint: Plasma concentration and pharmacokinetic parameters of lidocaine. Planned start Nov 2022; status: not yet recruiting.

02

Drugs

lidocaine
03

Conditions

obesity

Beyond the preview

Go deeper on ChiCTR2200064980.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200064980.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call